Works by Ramalingayya, Grandhi Venkata

Results: 18

Female rats induced with mammary cancer as a relevant animal model for doxorubicin-induced chemobrain in vivo.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 9, p. 862, doi. 10.1111/1440-1681.12596

By:

Ramalingayya, Grandhi Venkata;
Nayak, Pawan G;
Shenoy, Rekha R;
Rao, Chamallamudi Mallikarjuna;
Nandakumar, Krishnadas

Publication type:

Article

Assessment of female rats for studying episodic memory and its deficit associated with doxorubicin-induced chemobrain.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 6, p. 644, doi. 10.1111/1440-1681.12568

By:

Ramalingayya, Grandhi Venkata;
Gourishetti, Karthik;
Kishore, Anoop;
Nandakumar, Krishnadas

Publication type:

Article

Neuroprotective Potential of Methanolic Extract of Saraca asoca Bark against Doxorubicin-Induced Neurotoxicity.

Published in:

Pharmacognosy Magazine, 2019, v. 15, n. 61, p. 309, doi. 10.4103/pm.pm_79_18

By:

Cheruku, Sri Pragnya;
Chamallamudi, Mallikarjuna Rao;
Ramalingayya, Grandhi Venkata;
Biswas, Subhankar;
Gourishetti, Karthik;
Nandakumar, Krishnadas;
Devkar, Raviraj;
Mallik, Sanchari Basu;
Nampoothiri, Madhavan;
Kumar, Nitesh

Publication type:

Article

Naringin Ameliorates Doxorubicin-induced Neurotoxicity In vitro and Cognitive Dysfunction In vivo.

Published in:

Pharmacognosy Magazine, 2018, v. 14, p. S197, doi. 10.4103/pm.pm_364_17

By:

Ramalingayya, Grandhi Venkata;
Nayak, Pawan G.;
Shenoy, Rekha R.;
Mallik, Sanchari Basu;
Gourishetti, Karthik;
Hussain, Shalam M.;
Rao, Chamallamudi Mallikarjuna;
Nandakumar, Krishnadas

Publication type:

Article

Protective Effects of Aqueous Extract of Solanum nigrum Linn. Leaves in Rat Models of Oral Mucositis.

Published in:

Scientific World Journal, 2014, p. 1, doi. 10.1155/2014/345939

By:

Patel, Alkesh;
Biswas, Subhankar;
Shoja, Muhammed Haneefa;
Ramalingayya, Grandhi Venkata;
Nandakumar, K.

Publication type:

Article

5‐HT1A Receptor Agonist, SUVN‐N9503012 for the Treatment of Dementia and Associated Neuropsychiatric Disorders.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074640

By:

Abraham, Renny;
Petlu, Surendra;
Thentu, Jagadeesh Babu;
Grandhi, Venkata Ramalingayya;
Raya, Anji Reddy;
Ganuga, Narender;
Medapati, Rajesh Babu;
Subramanian, Ramkumar;
Rasheed, Mohammed Abdul;
Nirogi, Ramakrishna

Publication type:

Article

SUVN‐I6107: A True Positive Allosteric Modulator (PAM) at Muscarinic M1 Receptors for the Treatment of Cognitive Disorders.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074091

By:

Palacharla, Veera Raghava Chowdary;
Guduru, Naga Sai Soma Chandra Sekhar;
Medapati, Rajesh Babu;
Srirangavaram, Maheshwari;
Grandhi, Venkata Ramalingayya;
Ganuga, Narender;
Badange, Rajesh Kumar;
Nakka, Harish;
Subramanian, Ramkumar;
Nirogi, Ramakrishna

Publication type:

Article

SUVN‐I7016031: A Novel M1‐receptor Positive Allosteric Modulator (M1‐PAM) for the treatment of Parkinson's Disease Associated Dementia.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.062698

By:

Grandhi, Venkata Ramalingayya;
Ganuga, Narender;
Medapati, Rajesh Babu;
Tadiparthi, Jayaprakash;
Jayarajan, Pradeep;
Shinde, Anil K;
Badange, Rajesh Kumar;
Nirogi, Ramakrishna

Publication type:

Article

SUVN‐I6107: Efficacy and safety assessments of a true muscarinic M1‐positive allosteric modulator for the treatment of dementia.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051652

By:

Abraham, Renny;
Subramanian, Ramkumar;
Grandhi, Venkata Ramalingayya;
Muddana, NageswaraRao;
Kamuju, Venkatesh;
Badange, Rajesh Kumar;
Reballi, Veena;
Nirogi, Ramakrishna

Publication type:

Article

Masupirdine (SUVN‐502): A pure 5‐HT6 receptor antagonist ameliorates aggression‐like behavior in animal models: Development of new models and analysis methods/behavioral models.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039312

By:

Tadiparthi, Jayaprakash;
Ganuga, Narender;
Grandhi, Venkata Ramalingayya;
Medapati, Rajesh Babu;
Kamuju, Venkatesh;
Gandipudi, Sudhakar;
Reballi, Veena;
Jayarajan, Pradeep;
Nirogi, Ramakrishna

Publication type:

Article

SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits: Biomarkers (non‐neuroimaging)/Prognostic utility.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039288

By:

Abraham, Renny;
Goura, Venkatesh;
Grandhi, Venkata Ramalingayya;
Tadiparthi, Jayaprakash;
Ganuga, Narender;
Medapati, Rajesh Babu;
Muddana, Nageswara Rao;
Palacharla, Veera Raghava Chowdary;
Bhyrapuneni, Gopinadh;
Bojja, Kumar;
Mekala, Venkat Reddy;
Srirangavaram, Maheswari;
Badange, Rajesh Kumar;
Reballi, Veena;
Goyal, Vinod Kumar;
Pandey, Santosh Kumar;
Jayarajan, Pradeep;
Nirogi, Ramakrishna

Publication type:

Article

P2‐083: SUVN‐502: A PURE 5‐HT6 RECEPTOR ANTAGONIST AMELIORATES SENILE DEMENTIA IN ANIMAL MODELS.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P604, doi. 10.1016/j.jalz.2019.06.2490

By:

Grandhi, Venkata Ramalingayya;
Tadiparthi, Jayaprakash;
Ganuga, Narender;
Medapati, Rajesh Babu;
Talakanti, Hemasundar Reddy;
Abraham, Renny;
Jayarajan, Pradeep;
Saraf, Sangram Keshari;
Nirogi, Ramakrishna;
Jasti, Venkat

Publication type:

Article

P2‐094: SUVN‐502: A PURE 5‐HT6 RECEPTOR ANTAGONIST ALLEVIATES POST‐MENOPAUSE ASSOCIATED DEMENTIA IN AGED MENOPAUSE WISTAR RATS.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P703, doi. 10.1016/j.jalz.2018.06.779

By:

Venkata, Ramalingayya Grandhi;
Tadiparthi, Jayaprakash;
Ganuga, Narender;
Medapati, Rajesh Babu;
Talakanti, Hemasundar Reddy;
Abraham, Renny;
Jayarajan, Pradeep;
Nirogi, Ramakrishna

Publication type:

Article

P2‐080: SUVN‐502: A PURE 5‐HT6 ANTAGONIST AMELIORATES MEMORY DEFICIT IN TWO DIFFERENTIALLY CHALLENGED SOCIAL RECOGNITION TASKS.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P698, doi. 10.1016/j.jalz.2018.06.765

By:

Nirogi, Ramakrishna;
Venkata, Ramalingayya Grandhi;
Ganuga, Narender;
Talakanti, Hemasundar Reddy;
Jayarajan, Pradeep

Publication type:

Article

SUVN-502 (A PURE 5-HT6 ANTAGONIST): PROMISING THERAPEUTIC POTENTIAL FOR PMAD (POST-MENOPAUSE-ASSOCIATED DEMENTIA) AND SMAD (SURGICAL MENOPAUSE-ASSOCIATED DEMENTIA).

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P637, doi. 10.1016/j.jalz.2017.06.731

By:

Venkata, Ramalingayya Grandhi;
Tadiparthi, Jayaprakash;
Ganuga, Narender;
Jayarajan, Pradeep;
Nirogi, Ramakrishna

Publication type:

Article

NOVEL OBJECT RECOGNITION TASK: A SENSITIVE AND RELEVANT ANIMAL MODEL SYSTEM FOR EVALUATING POSTMENOPAUSE-RELATED DEMENTIA.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P287, doi. 10.1016/j.jalz.2017.06.187

By:

Venkata, Ramalingayya Grandhi;
Fernandes, Joylee;
Tadiparthi, Jayaprakash;
Ganuga, Narender;
Medapati, Rajesh Babu;
Jayarajan, Pradeep;
Nirogi, Ramakrishna

Publication type:

Article

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders.

Published in:

Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 309, doi. 10.3390/biom13020309

By:

Nirogi, Ramakrishna;
Jayarajan, Pradeep;
Shinde, Anil;
Mohammed, Abdul Rasheed;
Grandhi, Venkata Ramalingayya;
Benade, Vijay;
Goyal, Vinod Kumar;
Abraham, Renny;
Jasti, Venkat;
Cummings, Jeffrey

Publication type:

Article

Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses.

Published in:

2022

By:

Nirogi, Ramakrishna;
Jayarajan, Pradeep;
Benade, Vijay;
Shinde, Anil;
Goyal, Vinod Kumar;
Jetta, Satish;
Ravula, Jyothsna;
Abraham, Renny;
Grandhi, Venkata Ramalingayya;
Subramanian, Ramkumar;
Pandey, Santosh Kumar;
Badange, Rajesh Kumar;
Mohammed, Abdul Rasheed;
Jasti, Venkat;
Ballard, Clive;
Cummings, Jeffrey

Publication type:

journal article

Works by Ramalingayya, Grandhi Venkata

Female rats induced with mammary cancer as a relevant animal model for doxorubicin-induced chemobrain in vivo.

Assessment of female rats for studying episodic memory and its deficit associated with doxorubicin-induced chemobrain.

Neuroprotective Potential of Methanolic Extract of Saraca asoca Bark against Doxorubicin-Induced Neurotoxicity.

Naringin Ameliorates Doxorubicin-induced Neurotoxicity In vitro and Cognitive Dysfunction In vivo.

Protective Effects of Aqueous Extract of Solanum nigrum Linn. Leaves in Rat Models of Oral Mucositis.

5‐HT1A Receptor Agonist, SUVN‐N9503012 for the Treatment of Dementia and Associated Neuropsychiatric Disorders.

SUVN‐I6107: A True Positive Allosteric Modulator (PAM) at Muscarinic M1 Receptors for the Treatment of Cognitive Disorders.

SUVN‐I7016031: A Novel M<sub>1</sub>‐receptor Positive Allosteric Modulator (M<sub>1</sub>‐PAM) for the treatment of Parkinson's Disease Associated Dementia.

SUVN‐I6107: Efficacy and safety assessments of a true muscarinic M1‐positive allosteric modulator for the treatment of dementia.

Masupirdine (SUVN‐502): A pure 5‐HT<sub>6</sub> receptor antagonist ameliorates aggression‐like behavior in animal models: Development of new models and analysis methods/behavioral models.

SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits: Biomarkers (non‐neuroimaging)/Prognostic utility.

P2‐083: SUVN‐502: A PURE 5‐HT<sub>6</sub> RECEPTOR ANTAGONIST AMELIORATES SENILE DEMENTIA IN ANIMAL MODELS.

P2‐094: SUVN‐502: A PURE 5‐HT<sub>6</sub> RECEPTOR ANTAGONIST ALLEVIATES POST‐MENOPAUSE ASSOCIATED DEMENTIA IN AGED MENOPAUSE WISTAR RATS.

P2‐080: SUVN‐502: A PURE 5‐HT<sub>6</sub> ANTAGONIST AMELIORATES MEMORY DEFICIT IN TWO DIFFERENTIALLY CHALLENGED SOCIAL RECOGNITION TASKS.

SUVN-502 (A PURE 5-HT6 ANTAGONIST): PROMISING THERAPEUTIC POTENTIAL FOR PMAD (POST-MENOPAUSE-ASSOCIATED DEMENTIA) AND SMAD (SURGICAL MENOPAUSE-ASSOCIATED DEMENTIA).

NOVEL OBJECT RECOGNITION TASK: A SENSITIVE AND RELEVANT ANIMAL MODEL SYSTEM FOR EVALUATING POSTMENOPAUSE-RELATED DEMENTIA.

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders.

Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses.